A global network promoting objective and open debate on drug policy
This is the first study to demonstrate that impressive reductions in HCV incidence can be achieved among PWID over a relatively short time period through high coverage of a combination of interventions.
This year’s conference is a unique opportunity for a wide-ranging discussion and debate about tackling the treatment access issues of under-represented groups from those in the LGBT community and those using performance-enhancing drugs to military veterans.
Implementation of comprehensive harm reduction policies has achieved impressive reductions in incidence of hepatitis C virus (HCV) infections among people who inject drugs (PWID) in Scotland, research publish in PLOS ONE shows.
This conference will provide an opportunity to review current Harm Reduction practices both nationally & internationally and to examine the future potential for Harm Reduction within the recovery agenda.
Dr. Eliot Ross Albers, Executive Director of the International Network of People who Use Drugs discusses the importance of overcoming stigma, discrimination and criminalisation for drug users and key populations in general.
Stop AIDS commends the UK Department for International Development on its commitments to address HIV among key populations in developing countries, and reviews areas where DFID should take further action.